• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Peritoneal dissemination of gastric cancer stem cells and immunotherapy overcoming immune escape

Research Project

Project/Area Number 23591939
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Digestive surgery
Research Institution独立行政法人国立国際医療研究センター (2012-2013)
Kyushu University (2011)

Principal Investigator

TSUJITANI Shunichi  独立行政法人国立国際医療研究センター, その他部局等, その他 (30188544)

Co-Investigator(Kenkyū-buntansha) KEKEJI Yoshihiro  神戸大学, 大学院食道胃腸外科, 教授 (80284488)
MORIT Masaru  国立病院機構九州がんセンター, 消化器外科, 部長 (30294937)
KOHNOE Shunji  田川市立病院, 院長 (30215199)
EGASHIR Akinori  国立病院機構九州がんセンター, 消化器外科 (00419524)
SONODA Hideto  伊万里有田共立病院, 外科, 医長 (00465725)
OHGA Takefumi  国立病院機構福岡東医療センター, 外科, 部長 (60335958)
Project Period (FY) 2011 – 2013
Project Status Completed (Fiscal Year 2013)
Budget Amount *help
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2012: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2011: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Keywordsがん幹細胞 / 免疫回避機構 / 樹状細胞 / 免疫抑制 / 胃癌 / 腹膜播種
Research Abstract

Peritoneal dissemination of gastric cancer stem cells and immunotherapy overcoming immune escape were investigated. Cultured gastric cancer cell lines MKN45 and MKN74 were sorted by FACS int0 CD44+ and CD44- cells. CD44+ gastric cancer cells expressed TGF-b , IL-10 and VEGF. Therefore, gastric cancer stem cells may have high potential to escape from immune surveillance. However, CTL from healthy donor co-cultured with CD44+ gastric cancer cells could kill CD44+ gastric cancer cells as well as that CTL co-cultured with CD44- gastric cancer cells could kill CD44- gastric cancer cells. These results indicate that cancer stem cells may not be resistant to immunotherapy but the cancer stem cells may be protected by strong escape mechanisms provided by host cells.

Report

(4 results)
  • 2013 Annual Research Report   Final Research Report ( PDF )
  • 2012 Research-status Report
  • 2011 Research-status Report
  • Research Products

    (15 results)

All 2014 2013 2012 Other

All Journal Article (9 results) (of which Peer Reviewed: 7 results) Presentation (6 results)

  • [Journal Article] Feasibility study of alternate-day S-1 as adjuvant chemotherapy for gastric cancer : a randomized controlled trial2014

    • Author(s)
      Tatebe S, Tsujitani S, Nakamura S, Shimizu T, Yamane N, Nishidoi H, Kurisu Y,Kanayama H, Ogawa H, Ikeguchi M.
    • Journal Title

      Gastric Cancer

      Volume: 17(3) Issue: 3 Pages: 508-13

    • DOI

      10.1007/s10120-013-0289-z

    • NAID

      40020216078

    • Related Report
      2013 Final Research Report
  • [Journal Article] Development and external validation of a nomogram for overall survival after curative resection in serosa-negative, locally advanced gastric cancer2014

    • Author(s)
      Hirabayashi S, Kosugi S, Isobe Y, Nashimoto A, Oda I, Hayashi K, Miyashiro I,Tsujitani S, Kodera Y, Seto Y, Furukawa H, Ono H, Tanabe S, Kaminishi M, Nunobe S, Fukagawa T, Matsuo R, Nagai T, Katai H, Wakai T, Akazawa K.
    • Journal Title

      Ann Oncol

      Volume: 25 Issue: 6 Pages: 1179

    • DOI

      10.1093/annonc/mdu125

    • Related Report
      2013 Final Research Report
  • [Journal Article] Eur J Cancer2013

    • Author(s)
      Hidenori Takahashi
    • Journal Title

      10.1016/j.ejca.2012.11.005

      Volume: 49 Issue: 4 Pages: 852-859

    • DOI

      10.1016/j.ejca.2012.11.005

    • Related Report
      2013 Final Research Report 2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] Dendritic cell-based immunotherapy targeting synthesized peptides for advanced biliary tract cancer2013

    • Author(s)
      Kobayashi M, Sakabe T, Abe H, Tanii M, Takahashi H, Chiba A, Yanagida E,Shibamoto Y, Ogasawara M, Tsujitani S, Koido S, Nagai K, Shimodaira S, Okamoto M,Yonemitsu Y, Suzuki N, Nagaya M; DC-vaccine study group at the Japan Society of Innovative Cell Therapy (J-SICT).
    • Journal Title

      J Gastrointest Surg

      Volume: 17(9) Issue: 9 Pages: 1609-17

    • DOI

      10.1007/s11605-013-2286-2

    • Related Report
      2013 Annual Research Report 2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry2013

    • Author(s)
      Nashimoto A, Akazawa K, Isobe Y, Miyashiro I, Katai H, Kodera Y, Tsujitani S, Seto Y, Furukawa H, Oda I, Ono H, Tanabe S, Kaminishi M
    • Journal Title

      Gastric Cancer

      Volume: 16 Issue: 1 Pages: 1-27

    • DOI

      10.1007/s10120-012-0163-4

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] Relationship between expression of apoptosis-related proteins and the efficacy of postoperative chemotherapy in patients with T3 gastric cancer2012

    • Author(s)
      Tsujitani S, Saito H, Wakatsuki T, Ikeguchi M, Shirabe K, Morita M, Kakeji Y, Yano T, Maehara Y
    • Journal Title

      Surg Today

      Volume: 42 Issue: 3 Pages: 225-32

    • DOI

      10.1007/s00595-011-0062-z

    • NAID

      10030231066

    • Related Report
      2013 Final Research Report 2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] Biological mechanism and clinical effect of protein-bound polysaccharide K (KRESTIN([○!R])) : review of development and future perspectives2012

    • Author(s)
      Maehara Y, Tsujitani S, Saeki H, Oki E, Yoshinaga K, Emi Y, Morita M, Kohnoe S, Kakeji Y, Yano T, Baba H
    • Journal Title

      Surg Today

      Volume: 42 Issue: 1 Pages: 8-28

    • DOI

      10.1007/s00595-011-0075-7

    • NAID

      10030230106

    • Related Report
      2013 Final Research Report 2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] Role of tumor-associated macrophages in the progression of hepatocellular carcinoma2012

    • Author(s)
      Shirabe K, Mano Y, Muto J, Matono R, Motomura T, Toshima T, Takeishi K, Uchiyama H, Yoshizumi T, Taketomi A, Morita M, Tsujitani S, Sakaguchi Y, Maehara Y
    • Journal Title

      Surg Today

      Volume: 42 Issue: 1 Pages: 1-7

    • DOI

      10.1007/s00595-011-0058-8

    • NAID

      10030230041

    • Related Report
      2013 Final Research Report 2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] Prognostic effects of oral anti-cancer drugs as adjuvant chemotherapy for 2 years after gastric cancer surgery2012

    • Author(s)
      Okuyama T, Korenaga D, Edagawa A, Itoh S, Oki E, Kawanaka H, Ikeda Y, Kakeji Y, Tateishi M, Tsujitani S, Takenaka K, Maehara Y
    • Journal Title

      Surg Today

      Volume: 42 Issue: 8 Pages: 734-40

    • DOI

      10.1007/s00595-012-0129-5

    • NAID

      10030948984

    • Related Report
      2013 Final Research Report 2012 Research-status Report
    • Peer Reviewed
  • [Presentation] Immunohistochemical detection of human telomerase reverse transcriptase in human cholangiocarcinoma and risk condiction2013

    • Author(s)
      Endo K, Tsujitani S, Yoshimoto M, Watanabe J, Tokuyasu N, Sakamoto T, Naka T, Hirooka Y, Ikeguchi M.
    • Organizer
      American Association for Cancer Reserch Annual Meeting
    • Place of Presentation
      Washington DC, USA
    • Related Report
      2013 Final Research Report
  • [Presentation] Dendritic cell-based immunotherapy targeting WT1 and MUC1 for advanced biliary tract cancer2013

    • Author(s)
      Kobayashi M, Sakabe T, Tanii M, Abe H, Takahashi H, Tsujitani S, Shimodaira S, Yonemitsu Y, Okamoto M, Nagaya M.
    • Organizer
      American Association for Cancer Reserch Annual Meeting
    • Place of Presentation
      Washington DC, USA
    • Related Report
      2013 Final Research Report
  • [Presentation] Immunohistochemical detection of human telomerase reverse transcriptase in human cholangiocarcinoma and risk condition2013

    • Author(s)
      Endo K, Tsujitani S, Yoshimoto M, Watanabe J, Tokuyasu N, Sakamoto T, Naka T, Hirooka Y, Ikeguchi M
    • Organizer
      American Association for Cancer Research Annual Meeting
    • Place of Presentation
      Washington DC
    • Related Report
      2013 Annual Research Report
  • [Presentation] Dendritic cell-based immunotherapy targeting WT1 and MUC1 for advanced biliary tract cancer2013

    • Author(s)
      Kobayashi M, Sakabe T, Tanii M, Abe H, Takahashi H, Tsujitani S, Shimodaira S, Yonemitsu Y, Okamoto M, Nagaya M
    • Organizer
      American Association for Cancer Research Annual Meeting
    • Place of Presentation
      Washington DC
    • Related Report
      2013 Annual Research Report
  • [Presentation] Clinical evaluation of dendritic cell based vaccines pulsed with WT1 and /or MUC1 for patients with advanced or recurrent cancers2012

    • Author(s)
      Tsujitani S, Tnii M, Yonemitsu Y, Maehara M.
    • Organizer
      ESMO2012
    • Place of Presentation
      Vienna, Austria
    • Year and Date
      2012-10-12
    • Related Report
      2013 Final Research Report
  • [Presentation] Clinical evaluation of dendritic cell based vaccines pulsed with WT1 and/or MUC1 for patients with advanced or recurrent cancers

    • Author(s)
      Shunichi Tsujitani, Mitsugu Tanii, Yoshikazu Yonemitsu, Yoshihiko Maehara
    • Organizer
      ESMO 2012
    • Place of Presentation
      Vienna, Austria
    • Related Report
      2012 Research-status Report

URL: 

Published: 2011-08-05   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi